ADCompanion – a multi-center, randomized, non-inferiority study to compare the efficacy of a digital care concept for patients with atopic dermatitis with standard care

ADCompanion – a multi-center, randomized, non-inferiority study to compare the efficacy of a digital care concept for patients with atopic dermatitis with standard care - ADCompanion

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

DRKS

Registry ID

DRKS00030902

Enrollment

600

Registered

2023-05-22

Start date

2023-05-02

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L20.9

Interventions

Group 1: The intervention group will receive standard care WITHOUT access to atopmic dermatits face-to-face training, but with full use of the study app with vetted atopic dermatits educational conten

Eligibility

Sex/Gender

All

Age

3 Months to 65 Years

Inclusion criteria

Inclusion criteria: Covered by a statutory health insurance Age: 3 months to 17 years (children/adolescents) or 18-65 years (adults) Medically confirmed diagnosis of atopic dermatitis for at least 3 months SCORAD of at least 20 points Stable therapy regimen for 3 months (e.g. no new use of systemic therapies) Ownership of a smartphone with internet capability (for children under 14 years of age, ownership of the smartphone by the parents is decisive). Confident command of the German language (for young children, the parents' command of the German language is decisive).

Exclusion criteria

Exclusion criteria: 1. participation in an educational program for atopic dermatitis in the last 2 years (including inpatient rehabilitation). 2. participation in individual counseling in the areas of skin care, nutrition, and/or psychosocial issues in the past 12 months. 3. planned significant change in treatment regimen (e.g., first use of biologics) in the next 6 months 4. other serious medical conditions affecting the skin

Design outcomes

Primary

Measure	Time frame
Scoring Atopic Dermatitis Score (SCORAD), assessed 6 months after baseline	—

Secondary

Measure	Time frame
According to the age group of participants: PO-SCORAD EASi Skindex29 Infant´s Dermatitis Quality of Life Index Familien-Belastungs-Fragebogen FaBel (impact on family scale in families with children with disabilities) JUCKKI/ JUCKJU und COPEKI/COPEJU eHEALS: eHealth literacy scale Medication Diary Questionnaire on the use of medical services	—

Countries

Germany

Contacts

Public ContactJosephine Telschow

Klinik für Pädiatrie m.S. Pneumologie, Immunologie und Intensivmedizin, Charité Universitätsmedizin - Berlin

josephine.telschow@charite.de+49 30 450 559 839

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026